Inte:Ligand is participating in IMI project “eTox”
January 19th, 2010
Inte:Ligand will be participating in the eTOX project that aims at the in silico prediction of in vivo toxicities associated with drugs and drug candidates. The eTOX project is part of the first call of the Innovative Medicines Initiative (IMI) and it will be undertaken by a consortium composed of 11 big European pharmaceutical companies (EFPIA) and 12 academic institutions and small and medium enterprises. The project is officially starting on January 2010 and will be carried out until 2015.